126 related articles for article (PubMed ID: 11585368)
1. Autoantibodies to IA-2 and GAD65 in patients with type 2 diabetes mellitus of varied duration: prevalence and correlation with clinical features.
Grasso YZ; Reddy SK; Rosenfeld CR; Hussein WI; Hoogwerf BJ; Faiman C; Gupta MK
Endocr Pract; 2001; 7(5):339-45. PubMed ID: 11585368
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with the presence of glutamic acid decarboxylase and islet antigen-2 autoantibodies in patients with long-standing type 1 diabetes.
Wilmot-Roussel H; Lévy DJ; Carette C; Caillat-Zucman S; Boitard C; Timsit J; Dubois-Laforgue D
Diabetes Metab; 2013 May; 39(3):244-9. PubMed ID: 23522731
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune markers in slow type 1 diabetes: confrontation to type 1 diabetes.
Desailloud R; Fajardy I; Vambergue A; Prevost G; Pigny P; Fontaine P
Diabetes Metab; 2000 Nov; 26(5):353-60. PubMed ID: 11119014
[TBL] [Abstract][Full Text] [Related]
4. Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes.
Juneja R; Hirsch IB; Naik RG; Brooks-Worrell BM; Greenbaum CJ; Palmer JP
Metabolism; 2001 Sep; 50(9):1008-13. PubMed ID: 11555830
[TBL] [Abstract][Full Text] [Related]
5. Frequency of islet cell autoantibodies (IA-2 and GAD) in young Brazilian type 1 diabetes patients.
Pardini VC; Mourao DM; Nascimento PD; Vívolo MA; Ferreira SR; Pardini H
Braz J Med Biol Res; 1999 Oct; 32(10):1195-8. PubMed ID: 10510254
[TBL] [Abstract][Full Text] [Related]
6. Low prevalence of autoimmune diabetes markers in a mixed ethnic population of Singaporean diabetics.
Todd AL; Ng WY; Lui KF; Thai AC
Intern Med J; 2004; 34(1-2):24-30. PubMed ID: 14748910
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to glutamic acid decarboxylase and phenotypic features associated with early insulin treatment in individuals with adult-onset diabetes mellitus.
Humphrey AR; McCarty DJ; Mackay IR; Rowley MJ; Dwyer T; Zimmet P
Diabet Med; 1998 Feb; 15(2):113-9. PubMed ID: 9507910
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine phosphatase-like protein (IA-2) and glutamic acid decarboxylase (GAD65) autoantibodies: a study of Chinese patients with diabetes mellitus.
Ng WY; Lee YS; Todd AL; Lui KF; Loke KY; Thai AC
Autoimmunity; 2002 Mar; 35(2):119-24. PubMed ID: 12073931
[TBL] [Abstract][Full Text] [Related]
9. Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
Yasui J; Kawasaki E; Tanaka S; Awata T; Ikegami H; Imagawa A; Uchigata Y; Osawa H; Kajio H; Kawabata Y; Shimada A; Takahashi K; Yasuda K; Yasuda H; Hanafusa T; Kobayashi T;
PLoS One; 2016; 11(5):e0155643. PubMed ID: 27177031
[TBL] [Abstract][Full Text] [Related]
10. IgG1 subclass dominates autoimmune response to tyrosine phosphatase-like molecule IA-2 in Chinese type 1 diabetes patients.
Ng WY; Lui KF; Cheah JS; Thai AC
Horm Metab Res; 2002 Oct; 34(10):596-600. PubMed ID: 12439789
[TBL] [Abstract][Full Text] [Related]
11. GAD65 and IA-2 autoantibodies are common in a subset of siblings of Sardinian Type 2 diabetes families.
Maioli M; Tonolo G; Bekris L; Cirillo R; Schranz D; Cossu E; Ciccarese M; Lernmark A;
Diabetes Res Clin Pract; 2002 Apr; 56(1):41-7. PubMed ID: 11879720
[TBL] [Abstract][Full Text] [Related]
12. Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.
Maioli M; Alejandro E; Tonolo G; Gilliam LK; Bekris L; Hampe CS; Obinu DA; Manconi A; Puddu L; Lynch K; Lernmark A;
J Clin Endocrinol Metab; 2004 Nov; 89(11):5675-82. PubMed ID: 15531528
[TBL] [Abstract][Full Text] [Related]
13. Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies. Diabetes Incidence Study in Sweden (DISS).
Schranz DB; Bekris L; Landin-Olsson M; Törn C; Niläng A; Toll A; Sjöström J; Grönlund H; Lernmark A
Horm Metab Res; 2000 Apr; 32(4):133-8. PubMed ID: 10824708
[TBL] [Abstract][Full Text] [Related]
14. [A clinical analysis of insulin antibody in type 2 diabetic patients].
Ouyang XJ; Bian RW; Gu LB; Wu HD; Mo YZ; Lou QL; Yu Y
Zhonghua Nei Ke Za Zhi; 2016 Jul; 55(7):544-6. PubMed ID: 27373291
[TBL] [Abstract][Full Text] [Related]
15. Adult-onset autoimmune diabetes identified by glutamic acid decarboxylase autoantibodies: a retrospective cohort study.
Wada E; Onoue T; Kinoshita T; Hayase A; Handa T; Ito M; Furukawa M; Okuji T; Kobayashi T; Iwama S; Sugiyama M; Takagi H; Hagiwara D; Suga H; Banno R; Goto M; Arima H
Diabetologia; 2021 Oct; 64(10):2183-2192. PubMed ID: 34268631
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to glutamic acid decarboxylase (GAD) in non-obese Japanese diabetics without insulin therapy: a comparison of two commercial RIA kits based on recombinant and pig brain GAD.
Bando Y; Ushiogi Y; Toya D; Tanaka N; Fujisawa M
Diabetes Res Clin Pract; 1998 Jul; 41(1):25-33. PubMed ID: 9768369
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody against IA-2 improves the test sensitivity for insulin-dependent diabetes mellitus in Japanese patients of child onset.
Kasuga A; Ozawa Y; Maruyama T; Ishihara T; Amemiya S; Saruta T
Endocr J; 1997 Aug; 44(4):485-91. PubMed ID: 9447280
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to GAD and IA-2 in Saudi Arabian diabetic patients.
Damanhouri LH; Dromey JA; Christie MR; Nasrat HA; Ardawi MS; Robins RA; Todd I
Diabet Med; 2005 Apr; 22(4):448-52. PubMed ID: 15787671
[TBL] [Abstract][Full Text] [Related]
19. Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM.
Thai AC; Ng WY; Loke KY; Lee WR; Lui KF; Cheah JS
Diabetologia; 1997 Dec; 40(12):1425-30. PubMed ID: 9447950
[TBL] [Abstract][Full Text] [Related]
20. Islet cell, thyroid, adrenal and celiac disease related autoantibodies in patients with Type 1 diabetes from Sri Lanka.
Premawardhana LD; Wijeyaratne CN; Chen S; Wijesuriya M; Illangasekera U; Brooking H; Amoroso M; Jeffreys J; Bolton J; Lazarus JH; Furmaniak J; Rees Smith B
J Endocrinol Invest; 2006 Dec; 29(11):968-74. PubMed ID: 17259793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
